Document Detail

Efficacy of beta-adrenergic blocker plus 5-isosorbide mononitrate and endoscopic band ligation for prophylaxis of esophageal variceal rebleeding: a meta-analysis.
MedLine Citation:
PMID:  19418589     Owner:  NLM     Status:  MEDLINE    
AIM: To systematically assess the efficacy and safety of beta-adrenergic blocker plus 5-isosorbide mononitrate (BB + ISMN) and endoscopic band ligation (EBL) on prophylaxis of esophageal variceal rebleeding.
METHODS: Randomized controlled trials (RCTs) comparing the efficacy and safety of BB + ISMN and EBL on prophylaxis of esophageal variceal rebleeding were gathered from Medline, Embase, Cochrane Controlled Trial Registry and China Biological Medicine database between January 1980 and August 2007. Data from five trials were extracted and pooled. The analyses of the available data using the Revman 4.2 software were based on the intention-to-treat principle.
RESULTS: Four RCTs met the inclusion criteria. In comparison with BB + ISMN with EBL in prophylaxis of esophageal variceal rebleeding, there was no significant difference in the rate of rebleeding [relative risk (RR), 0.79; 95% CI: 0.62-1.00; P = 0.05], bleeding-related mortality (RR, 0.76; 95% CI: 0.31-1.42; P = 0.40), overall mortality (RR, 0.81; 95% CI: 0.61-1.08; P = 0.15) and complications (RR, 1.26; 95% CI: 0.93-1.70; P = 0.13).
CONCLUSION: In the prevention of esophageal variceal rebleeding, BB + ISMN are as effective as EBL. There are few complications with the two treatment modalities. Both BB + ISMN and EBL would be considered as the first-line therapy in the prevention of esophageal variceal rebleeding.
Shi-Hua Ding; Jun Liu; Jian-Ping Wang
Related Documents :
16567189 - Extracellular matrix dynamics associated with tissue-engineered intravascular sclerothe...
10094949 - Cost analysis for the prevention of variceal rebleeding: a comparison between transjugu...
2784259 - Percutaneous transhepatic embolization of gastroesophageal varices: results in 400 pati...
9790199 - Comparative study of 2 variants of a modified esophageal transection in the sugiura-fut...
2033689 - Microsurgical treatment of chyluria: a preliminary report.
15627779 - Management of pelvic lymphocysts by ultrasound-guided aspiration and minocycline sclero...
24550439 - Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent:...
11718169 - Verteporfin: new preparation. in combination with laser therapy: helpful in some forms ...
22113209 - Upper gastrointestinal bleeding: predictors of risk in a mixed patient group including ...
Publication Detail:
Type:  Journal Article; Meta-Analysis    
Journal Detail:
Title:  World journal of gastroenterology : WJG     Volume:  15     ISSN:  2219-2840     ISO Abbreviation:  World J. Gastroenterol.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-05-06     Completed Date:  2009-07-28     Revised Date:  2014-05-20    
Medline Journal Info:
Nlm Unique ID:  100883448     Medline TA:  World J Gastroenterol     Country:  China    
Other Details:
Languages:  eng     Pagination:  2151-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use*
Esophageal and Gastric Varices / etiology,  prevention & control*,  therapy
Isosorbide Dinitrate / analogs & derivatives*,  therapeutic use
Liver Cirrhosis / complications
Randomized Controlled Trials as Topic
Treatment Outcome
Vasodilator Agents / therapeutic use*
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Vasodilator Agents; 16051-77-7/isosorbide-5-mononitrate; IA7306519N/Isosorbide Dinitrate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinicopathological significance of B-cell-specific Moloney murine leukemia virus insertion site 1 e...
Next Document:  Unusual presentations of eosinophilic gastroenteritis: case series and review of literature.